GUJRATHI SHEILA
Insider CIK 1575202 · FPRX Director · RCPT Chief Medical Officer · PCSA Director · TPTX Director · BOLT Chief Strategy Officer, Director · GOSS President & CEO, Director · JANX Director · VTYX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BOLT Bolt Biotherapeutics, Inc. | J Other deriv | 2026-10-23 | 2026-10-27 | 496 | — | — | 496 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | J Other deriv | 2026-10-23 | 2026-10-27 | 2,764 | — | — | 2,764 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award | 2026-10-23 | 2026-10-27 | 13,055 | — | $0 | 13,055 | SEC↗ |
| BOLT Bolt Biotherapeutics, Inc. | A Award | 2026-10-23 | 2026-10-27 | 72,766 | — | $0 | 72,766 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2026-07-28 | 2026-07-30 | 12,311 | — | $0 | 12,311 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2026-07-28 | 2026-07-30 | 70,812 | — | $0 | 70,812 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2026-07-28 | 2026-07-30 | 12,311 | — | — | 12,311 | SEC↗ |
| PCSA Processa Pharmaceuticals, | A Award deriv | 2026-07-28 | 2026-07-30 | 70,812 | — | — | 70,812 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | D To issuer deriv | 2026-03-04 | 2026-03-04 | 15,937 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | D To issuer deriv | 2026-03-04 | 2026-03-04 | 21,825 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | D To issuer deriv | 2026-03-04 | 2026-03-04 | 33,000 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | D To issuer deriv | 2026-03-04 | 2026-03-04 | 40,000 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | D To issuer deriv | 2026-03-04 | 2026-03-04 | 80,000 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | D To issuer deriv | 2026-03-04 | 2026-03-04 | 277,941 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | D To issuer deriv | 2026-03-04 | 2026-03-04 | 662,369 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | D To issuer | 2026-03-04 | 2026-03-04 | 130,000 | — | $0 | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2025-06-11 | 2025-06-13 | 11,667 | — | $0 | 11,667 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2025-06-11 | 2025-06-13 | 3,750 | — | $0 | 118,889 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | P Buy | 2024-12-23 | 2024-12-26 | 130,000 | $2.31 | $300.3K | 130,000 | SEC↗ |
| JANX Janux Therapeutics, Inc. | J Other | 2024-11-05 | 2024-11-07 | 4,611 | — | $0 | 115,139 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2024-06-26 | 2024-06-28 | 8,350 | — | $0 | 8,350 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award | 2024-06-26 | 2024-06-28 | 2,500 | — | $0 | 110,528 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2024-06-06 | 2024-06-07 | 33,000 | — | $0 | 33,000 | SEC↗ |
| JANX Janux Therapeutics, Inc. | J Other | 2024-02-29 | 2024-03-04 | 2,986 | — | $0 | 108,028 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2024-01-21 | 2024-01-23 | 80,000 | — | $0 | 80,000 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 15,937 | — | $0 | 15,937 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | M Exercise deriv | 2023-03-30 | 2023-03-31 | 100,000 | — | $0 | 662,369 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | M Exercise | 2023-03-30 | 2023-03-31 | 100,000 | $6.03 | $603.0K | 100,000 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | S Sale | 2023-03-30 | 2023-03-31 | 100,000 | $33.73 | $3.37M | 0 | SEC↗ |
| JANX Janux Therapeutics, Inc. | A Award deriv | 2022-06-14 | 2022-06-16 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2022-06-09 | 2023-04-26 | 21,825 | — | $0 | 21,825 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 13,301 | — | $0 | 13,301 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2021-12-02 | 2021-12-03 | 277,941 | — | $0 | 277,941 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | C Conversion deriv | 2021-10-25 | 2021-10-25 | 32,897 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | C Conversion | 2021-10-25 | 2021-10-25 | 32,897 | — | $0 | 32,897 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2020-06-15 | 2020-06-17 | 8,500 | — | $0 | 8,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2020-02-14 | 2020-02-19 | 292,000 | — | $0 | 292,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award | 2020-02-14 | 2020-02-19 | 189,500 | — | $0 | 189,500 | SEC↗ |
| GOSS Gossamer Bio, Inc. | P Buy | 2019-09-27 | 2019-09-27 | 10,000 | $16.80 | $168.0K | 4,048,242 | SEC↗ |
| TPTX Turning Point Therapeutics | A Award deriv | 2019-04-22 | 2019-04-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | A Award deriv | 2019-03-25 | 2019-03-26 | 380,000 | — | $0 | 380,000 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-12 | 223,182 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion deriv | 2019-02-12 | 2019-02-12 | 55,957 | — | $0 | 0 | SEC↗ |
| GOSS Gossamer Bio, Inc. | C Conversion | 2019-02-12 | 2019-02-12 | 62,030 | — | $0 | 4,038,242 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2018-05-10 | 2018-05-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2017-05-10 | 2017-05-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2016-05-19 | 2016-05-23 | 10,000 | — | $0 | 0 | SEC↗ |
| FPRX FIVE PRIME THERAPEUTICS IN | A Award deriv | 2015-12-02 | 2015-12-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 26,666 | $223.90 | $5.97M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 129,400 | $213.23 | $27.59M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 55,418 | $190.49 | $10.56M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer | 2015-08-27 | 2015-08-27 | 12,500 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | U Tender | 2015-08-25 | 2015-08-27 | 120,661 | — | $0 | 12,500 | SEC↗ |
| RCPT Receptos, Inc. | A Award | 2015-04-01 | 2015-04-03 | 12,500 | — | $0 | 133,161 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2014-11-11 | 2014-11-12 | 30,000 | $108.99 | $3.27M | 120,661 | SEC↗ |
| RCPT Receptos, Inc. | S Sale | 2014-09-22 | 2014-09-24 | 30,000 | $61.45 | $1.84M | 150,661 | SEC↗ |
| RCPT Receptos, Inc. | A Award deriv | 2014-04-03 | 2014-04-07 | 55,418 | — | $0 | 55,418 | SEC↗ |
| RCPT Receptos, Inc. | A Award deriv | 2013-07-17 | 2013-07-19 | 129,400 | — | $0 | 129,400 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion deriv | 2013-05-14 | 2013-05-14 | 100,000 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | C Conversion | 2013-05-14 | 2013-05-14 | 13,333 | $5.25 | $70.0K | 180,661 | SEC↗ |